Nanotechnology in medicine—nanomedicine—is extensively employed to diagnose, treat,
and prevent pulmonary diseases. Over the last few years, this brave new world has made …

Inflammation-associated diseases encompass a range of infectious diseases and non-
infectious inflammatory diseases, which continuously pose one of the most serious threats to …

Acute lung injury (ALI) or its aggravated stage acute respiratory distress syndrome (ARDS)
may lead to a life-threatening form of respiratory failure, resulting in high mortality of up to 30 …

Macrophages are considered as the most flexible cells of the hematopoietic system that are
distributed in the tissues to act against pathogens and foreign particles. Macrophages are …

Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems
explores the development of novel therapeutics and diagnostics to improve pulmonary …

Introduction Macrophages are involved in the normal defense of the body; however, the
varying phenotypes of macrophages and imbalance in their ratio lead to the impairment of …

Respiratory viral infections are major cause of highly mortal pandemics. They are impacting
socioeconomic development and healthcare system globally. These emerging deadly …

Acute respiratory distress syndrome (ARDS) is characterized by the severe inflammation
and destruction of the lung air–blood barrier, leading to irreversible and substantial …

The lack of effective treatments for pulmonary diseases presents a significant global health
burden, primarily due to the challenges posed by the pulmonary barrier that hinders drug …

Most lung diseases, including acute respiratory distress syndrome, cystic fibrosis, chronic
obstructive pulmonary disease (COPD), interstitial lung disease and asthma, have …